Diabetes Testing Centers™
Chronic Risk
Screening &
Assessments
Screen. Test. Treat.
TriageIQ™ | Universal Chronic Screener. Every Adult.
Diabetes Testing Centers™
Chronic Risk
Screening &
Assessments
Screen. Test. Treat.
The earliest signals of chronic disease rarely appear in isolation, and may not show up in labs. They emerge in the patient — through symptoms, functional change, and subtle clinical patterns that precede what is formally documented in the chart.
Leading PCP clinics distinguish themselves by identifying what others miss — connecting risk factors across conditions and recognizing patterns others overlook. A structured, scalable screening approach brings that capability to the front end of care, helping surface early signals, strengthen documentation, and direct the next appropriate clinical step before preventable decline leads to disability, loss of independence, or serious complication.
What Others Miss
Diabetes Testing Centers™ (DTC) was founded by former family practice owners shaped by firsthand experience with late detection and preventable complications in everyday care. That perspective was further informed by enterprise healthcare management leadership in diagnostics and diabetes — guiding DTC's development of scalable, non-invasive, reimbursable point-of-care programs. Today, with a national network of more than 20,000 independent practices, DTC helps CMS-ready and cash-pay providers identify patient risks within the same visit through rapid, objective chronic risk screeners and assessments.
Chronic Risk Across Five Domains
🧩 Behavioral Risk. Depression, sleep disorders, and behavioral health conditions directly worsen chronic disease outcomes. Early identification enables timely support and coordinated care.
❤️ Cardiometabolic Risk. Hypertension, diabetes complications, and vascular disease frequently progress without warning. Early screening reduces the risk of heart attack, stroke, and serious complications.
🧠 Neurological Risk. Silent nerve and brain changes — including cognitive decline, neuropathy, and fall risk — often appear years before symptoms. Early detection allows providers to intervene before irreversible damage occurs.
⚡ Pain & Function Risk. In diabetes and other chronic conditions, silent lower-extremity decline may be as important as pain. Routine screening helps identify early risk before instability, ulceration, or amputation.
🔎 Population Health Risk. Establishes the patient's baseline risk profile before the encounter begins — determining care pathway and how every downstream signal is interpreted.
TriageIQ™ is a proprietary universal chronic screener that identifies risk across five domains in about 3 minutes, while supporting medical necessity for further assessment in each domain identified.
Detecting these risks earlier helps protect patients before complications become life-altering. DTC delivers the clinical science behind Chronic Risk Assessments trusted by specialists nationwide. Clinics can onboard flexibly, integrate seamlessly into existing workflows, and begin generating recurring revenue in under 30 days*. Networks, ACOs, and MSOs can deploy the same approach consistently across every site they support.
Diabetes Damages. We Find Where.
Early Detection Gives Families More Time and Memories to Share.
Diabetes Testing Centers™ (DTC) helps medical providers unlock the full value of earlier detection by moving beyond routine glucose checks and bringing more meaningful chronic disease insight into the exam room. Through CMS-billable assessments, non-invasive point-of-care diagnostics, and structured chronic-care pathways, DTC helps clinics identify risk sooner, act earlier, and keep more appropriate care under one roof.
Routine visits, including Annual Wellness Visits (AWVs), can become more clinically productive when supported by faster assessments, stronger documentation, and reimbursable diagnostic tools that fit naturally into existing workflows. DTC makes that possible through practical programs designed to improve early detection without adding operational burden.
Our exclusive Chronic Care Programs are built for primary care and multispecialty practices and can often be implemented in a single room without new staff, new construction, or major disruption. These CMS-ready and cash-ready programs help clinics use time more efficiently, expand in-house services, and deliver compliant, non-invasive assessments that support both outcomes and revenue.
TriageIQ™ anchors the intake process, ensuring the right downstream assessments are identified before the patient leaves the visit.
CMS-Ready and Cash-Ready
Aligned with National Guidelines
Annual neuropathy screening for every diabetic patient is the standard of care — recommended across primary care, endocrinology, podiatry, and neuropathy practice guidelines. The challenge isn't knowing it should happen. The challenge is making it happen consistently in a busy clinic.
Neuropathy is one of the earliest and most common complications of diabetes, and the distinction between fiber types matters clinically:
Small fiber neuropathy is often the earliest sign of metabolic dysfunction or poorly controlled diabetes. It signals that systemic complications may already be developing, even before the patient reports symptoms.
Large fiber neuropathy carries loss of protective sensation — the direct pathway to falls, ulcers, infections, and lower-extremity amputation. Once identified, protective sensation should be reassessed at every visit.
Neuropathy rarely travels alone. When it's present, the same underlying metabolic process is almost always active elsewhere — cardiovascular disease, renal decline, and vision loss share the same origin. Finding neuropathy early is a signal to look for the rest.
Where TriageIQ™ Comes In
TriageIQ™ is the front-door mechanism that makes guideline-concordant screening systematic, not dependent on provider recall. At intake, patients complete TriageIQ™ in 3 minutes. Signals across five domains are surfaced before the provider enters the room. Patients flagged for neurological risk move directly into DTC's neuropathy testing workflow. Patients flagged in multiple domains move into the broader chronic care program stack.
When you can screen, test, and treat in-house and remotely, patients stay under your care — and the chain reaction stops at its source. That's what DTC's chronic care programs are built for: not a menu of assessments, but an integrated detection and care platform operating under one roof.
Consolidated Care
Healthcare organizations may become a licensed Diabetes Testing Centers™ (DTC) partner that supports the screening, testing, and treatment of chronic disease risks through proprietary rapid, non-invasive, reimbursable workflows.
Most chronic disease does not begin with a diagnosis. It begins with early changes in symptoms, function, and patient-reported risk that often go unrecognized during intake. When those signals are missed, the clinical pathway starts too late — referrals are delayed, urgency is reduced, and disease progresses silently.
TriageIQ™ moves structured risk detection to the front end of care. Instead of waiting for symptoms to worsen or a specialist to surface a problem later, providers begin with multi-domain insight at intake. The visit stays familiar, the pathway becomes earlier, clearer, and more clinically actionable.
Traditional front-end screening in many primary care settings is limited, inconsistent, outdated, or non-reimbursable. DTC modernizes that process by combining structured intake, billable assessments, and non-invasive diagnostics into a more actionable care pathway.
Our Chronic Care Programs help providers act on what intake reveals. Through targeted assessments, reimbursable diagnostics, and scalable workflows, clinics can close care gaps, support earlier intervention, and reduce unnecessary referral leakage — without disrupting the core visit.
Test Patient Signals
Start by improving intake — then let the patient signals show you where the biggest clinical and financial opportunities already exist in your practice and get started on testing.
Getting Started Is Simple:
Start with TriageIQ™ at Intake
Use TriageIQ™ as the front door for adult patients to identify early multi-domain risk signals quickly and consistently at the beginning of care.
Identify the Risk Patterns Showing Up in Your Clinic
As intake findings begin to surface patterns, your clinic can see which chronic disease domains are appearing most often and where additional in-house assessment may be most valuable.
Address the Highest-Value Assessments in a 30–60–90 Day Rollout
TriageIQ™ begins creating value at intake immediately. Some patients may warrant targeted next-step assessment right away, while the strongest clinic-wide clinical and financial opportunities typically become clear within the first 30 to 90 days of consistent use:
• 30 days: identify where hidden demand exists
• 60 days: begin focusing on the highest-priority downstream assessments
• 90 days: confirm the most valuable clinical assessments and operational opportunities
Schedule a Meeting to Build Your Rollout Plan. We help you determine the best starting point, review program options, and provide a financial pro forma based on your location, workflow, and payor mix so you can begin implementation with a clear path to deployment.
Start at Intake
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.